Charlene Foley
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charlene Foley.
Pediatric Rheumatology | 2014
Charlene Foley; Emma Jane MacDermott; Orla Killeen
The ‘Arthropathy of Down syndrome’ was first described in 1984. Three decades on we still have limited literature on the clinical and radiological features of this arthritis, despite the fact that it is thought to be 3-6 times more common than JIA in the general paediatric population. Down’s Arthropathy (DA) is rarely recognised at onset, and remains under-diagnosed and largely under-reported in this population group. Ireland has one of the highest Trisomy 21 birth rates in Europe (1/547), & therefore provides an ideal setting for such a study. Research Qs - 1. What are the clinical & radiological features of DA? 2. Is DA missed, leading to a delay in dx?
Pediatric Rheumatology | 2014
Charlene Foley; Emma Jane MacDermott; Orla Killeen
Musculoskeletal complications of Down syndrome are common. Joint laxity, which may be associated with delayed ambulation, is almost universal. The combination of this ligamentous laxity and low muscle tone contribute to an increased risk of a number of musculoskeletal disorders in children with Down syndrome.
Pediatric Rheumatology | 2014
Charlene Foley; Emma Jane MacDermott; Orla Killeen
JIA is an umbrella term used to describe a heterogeneous group of diseases. To date no specific markers exist in clinical practice to predict disease activity & outcome. MRP 8/14 are calcium-binding proteins secreted by infiltrating phagocytes in synovial inflammation. Studies have shown that serum (Se) concentrations correlate sensitively & specifically with synovial inflammation in JIA. It is believed that they are predictive biomarkers that can identify subclinical disease activity, patients at risk of relapse during times of clinically inactive disease, and patients more likely to respond to Rx with MTX. To date there have been no studies looking specifically at their use in DA. Research Q(s) - 1. Are MRP8/14 accurate markers of inflammation in DA? 2. Do MRP 8/14 levels in Se correlate to Synovial Fluid (SF)?
Rheumatology | 2018
Ethan S Sen; Beverley Almeida; Louise Moran; Charlene Foley; Rosie Close; Ema-Louise Long; Joshua Bennett; Jason Palman; Catriona M Anderson; Kirsty McLellan; Samundeeswari Deepak; Kathy Gallagher; Peter Bale; Kamran Mahmood; Clare Pain; Flora McErlane; Athimalaipet V Ramanan; Rachel Tattersall
Rheumatology | 2017
Wafa Madan; Charlene Foley; Ciara Lang; Orla Killeen; Emma Jane MacDermott
Rheumatology | 2017
Charlene Foley; Emma Jane Mac Dermott; Aisling Snow; Orla Killeen
Rheumatology | 2016
Charlene Foley; Orla Killeen; Emma Jane MacDermott; Douglas J. Veale
Rheumatology | 2016
Charlene Foley; Orla Killeen; Emma Jane MacDermott; Douglas J. Veale; Ursula Fearon
Rheumatology | 2015
Charlene Foley; Emma Jane MacDermott; Orla Killeen
Rheumatology | 2015
Charlene Foley; Emma Jane MacDermott; Orla Killeen